Anavex Life Sciences Corp (AVXL)

[xodcode]

It is worth repeating, a primary reason for investing in AVXL:

Specific genetic features, shared by about 80% of the study participants,in phase 2a, correlated with a strong, "clinically meaningful" response to the medicine(A2-73), Hampel said.

Seems like a favourable AVXL risk/reward equation at current price level, given Mr. Hampel's statement.